Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies.

Lorena Goldring Beena Kumar T Eng Gan Michael Sze Yuan Low

Pathology

Department of Immunology, Monash University, Prahran, Vic, Australia; Monash Haematology, Monash Health, Clayton, Vic, Australia; Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Vic, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Vic, Australia. Electronic address:

Published: August 2017

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.pathol.2017.03.009	DOI Listing

Publication Analysis

Top Keywords

idelalisib induced

induced cmv

cmv gastrointestinal

gastrointestinal disease

disease vigilance

vigilance novel

novel therapies

idelalisib

cmv

gastrointestinal

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!